Embryos with abnormal chromosomes (also called aneuploid embryos) normally result in a miscarriage or may lead to the birth of a child with genetic condition.

PGT-A is particularly important for female patients over age 35, as the risk of chromosomal abnormality increases with maternal age.

PGT-A (also known as PGS, Preimplantation Genetic Screening) is a genetic testing, performed on an in vitro fertilized embryo- before the  embryo gets transferred, to screen the embryo’s genetic health, so that your physician could select the best embryo for implantation and increased the chance of a successful pregnancy.

Moreover, PGT-A can greatly reduce the chances of a patient having multiple pregnancies by providing information to select the optimal embryo for Single Embryo Transfer.

Expanded Carrier Screening适合对象：

• Advanced maternal age.
• Couples with infertility concerns.
• Couples with recurrent miscarriages.
• Couples with many failed IVF cycles.
• Couples with a family history of chromosomal abnormalities.
• Couples undergoing IVF treatment for other reasons.

PGT-A can also be done in conjunction with MIRA to increase the chance of implantation: Choose the best embryo transfer at the right time!

Find out more for MIRA test